Project Grant R21DA061405
Award Date
7/15/25
Completion Date
6/30/27
Dollars Obligated
$437K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
La Jolla, CA 92093, USA
Similar Awards
This federal Project Grant award of $703,457, awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund a longitudinal study to investigate the relationship between adolescent social media use and substance use. The primary goals are to: 1) Determine longitudinal associations and sensitive developmental windows linking social media use with substance use, 2) Identify mechanisms connecting social media use and substance use,...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $400,000 to Mountainpass Technology LLC to develop, refine, and evaluate a customized version of their "MyTrials" integrated remote biomarker capture system for decentralized clinical trials (DCTs) focused on substance use disorders (SUDs). The project aims to address key methodological limitations of DCTs for SUDs by creating a product...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), provides $720,763 to Virginia Commonwealth University (VCU) to investigate the risk and protective factors associated with substance use trajectories in adolescents. The 4-year study will leverage data from the Adolescent Brain Cognitive Development (ABCD) study, which includes a large, nationwide sample of over 11,000 youth, as well as longitudinal...
This federal Project Grant award of $840,425.00 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports research examining the impact of prenatal and postnatal substance exposure on adolescent risk behaviors. The award to The Pennsylvania State University will leverage a longitudinal sample of 247 families to investigate developmental cascades linking pre- and post-natal substance use risks to adolescent substance use,...
This Project Grant award of $1,607,146.00 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports the development of a technology-based intervention to encourage drug checking, distribution of harm reduction supplies, and linkage to services for people who use drugs. The project, titled "Together Against Overdose: Community Developed Technology to Encourage Drug Checking, Distribution of Harm Reduction Supplies, and...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), provides $973,442 to the University of California, San Francisco (UCSF) to study the effectiveness of the FOSTRSPACE digital substance use prevention intervention and the Extension for Community Healthcare Outcomes (ECHO) implementation strategy for delivering the intervention to foster youth. The study aims to assess FOSTRSPACE's reach and...
The National Institute on Drug Abuse (NIDA) awarded a $445,000 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to The Children's Hospital Corporation, doing business as Boston Children's Hospital. The grant will fund the development and pilot testing of a novel telehealth and mobile health intervention called MOMENT-V to address cannabis use disorder in young adults seen in primary care. The intervention combines motivational enhancement therapy delivered via...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), provides $280,207 to Mobile Health Interventions LLC to develop a digital intervention called the Adolescent CLEAR30 to reduce cannabis use among youth aged 13-17. The proposed intervention will include personalized feedback, daily communications, guided meditations, resource pages, multimedia content, optional human support, and an AI-driven...
This $2,419,326 Project Grant awarded by the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports a longitudinal study to investigate neurobehavioral and psychosocial predictors of health risk behaviors (HRBs) in adolescence and young adulthood. The primary awardee, Virginia Polytechnic Institute & State University, will conduct assessments over 15 years to understand brain development and its impact on substance use and...
The National Institute on Drug Abuse (NIDA) awarded a $1,076,018 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Dynamicare Health Inc. in Wareham, MA. The award will fund a Phase II randomized clinical trial to evaluate the efficacy of DCH-003, a digital therapeutic that delivers contingency management for the treatment of stimulant use disorder. The trial will compare standard clinic care plus DCH-003 to standard care plus a sham digital app, with the...